| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1934667 | Biochemical and Biophysical Research Communications | 2008 | 5 Pages |
We previously showed that antral gastric tumors develop in gastrin-deficient (Gas−/−) mice. Therefore Gas−/−mice were studied sequentially over 12 months to identify molecular mechanisms underlying gastric transformation. Fundic atrophy developed by 9 months in Gas−/− mice. Antral mucosal hyperplasia developed coincident with the focal loss of TFF1 and Muc5AC. Microarray analysis of 12 month Gas−/− tumors revealed an increase in follistatin, an activin/BMP antagonist. We found that elevated follistatin expression occurred in the proliferative neck zone of hyperplastic antrums, in antral tumors of Gas−/− mice, and also in human gastric cancers. Follistatin induced cyclin D1 and the trefoil factors TFF1 and TFF2 in a gastric cancer cell line. We concluded that antral hyperplasia in Gas−/− mice involves amplification of mucous cell lineages due to follistatin, suggesting its role in the development of antral gastric tumors.
